Effects of herb-partitioned moxibustion for ulcerative colitis A protocol for systematic review and meta-analysis

被引：2
作者：
Yan, Xiao [1 ]
Ma, Fengjun [1 ]
Yu, Yanpu [1 ]
Du, Dongqing [1 ]
Wang, Zhilei [1 ]
Chen, Chen [1 ]
Zhang, Xiaobin [1 ]
Sun, Xiao [1 ]
Dong, Zhibin [1 ]
Ma, Yuxia [1 ]
Ma, Yuning [1 ]
机构：
[1] Shandong Univ Tradit Chinese Med, Sch Acupuncture Tuina, Jinan, Shandong, Peoples R China
来源：
MEDICINE | 2020年 / 99卷 / 31期
基金：
中国国家自然科学基金;
关键词：
herb-partitioned moxibustion; meta-analysis; protocol; systematic review; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; EPIDEMIOLOGY; PREVALENCE;
D O I：
10.1097/MD.0000000000021319
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease of the colonic mucosa. Herb-partitioned moxibustion (HPM) treatment has been demonstrated to be effective in the treatment of UC. However, there is still a lack of high-quality evidence to support the effectiveness and safety of HPM on patients with UC. This study will aim to systematically explore the efficacy of HPM for the treatment of UC. Methods: We will search the electronic databases of Embase, MEDLINE, PubMed, Cochrane Library Central Register of Controlled Trials, China national knowledge infrastructure database (CNKI), Wan fang database, Chongqing VIP information, and SinoMed from their inception to June 2020. Randomized controlled trials (RCTs) of HPM for the treatment of UC will be included. RevMan 5.3 software (The Nordic Cochrane Center, The Cochrane Collaboration, Copenhagen, Denmark) will be applied for statistical analysis. Results: The results of this study will be published in a peer-reviewed journal. Conclusion: The conclusion of our systematic review will provide more appropriate evidence-based decisions to assist clinicians during the decision-making process when dealing with UC.
引用
收藏
页数：4
相关论文
共 17 条
[1]   Inflammatory bowel disease epidemiology [J].
Burisch, Johan ;
Munkholm, Pia .
CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (04) :357-362
[2]   Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response [J].
Furrie, E ;
Macfarlane, S ;
Cummings, JH ;
Macfarlane, GT .
GUT, 2004, 53 (01) :91-98
[3]   Quantifying heterogeneity in a meta-analysis [J].
Higgins, JPT ;
Thompson, SG .
STATISTICS IN MEDICINE, 2002, 21 (11) :1539-1558
[4]   Typical ulcerative colitis treated by herbs-partitioned moxibustion: A case report [J].
Lin, Ya-Ying ;
Zhao, Ji-Meng ;
Ji, Ya-Jie ;
Ma, Zhe ;
Zheng, Han-Dan ;
Huang, Yan ;
Cui, Yun-Hua ;
Lu, Yuan ;
Wu, Huan-Gan .
WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (08) :1515-1524
[5]   Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences [J].
Loftus, EV .
GASTROENTEROLOGY, 2004, 126 (06) :1504-1517
[6]  
Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1371/journal.pmed.1000097, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2535]
[7]   Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies [J].
Ng, Siew C. ;
Shi, Hai Yun ;
Hamidi, Nima ;
Underwood, Fox E. ;
Tang, Whitney ;
Benchimol, Eric I. ;
Panaccione, Remo ;
Ghosh, Subrata ;
Wu, Justin C. Y. ;
Chan, Francis K. L. ;
Sung, Joseph J. Y. ;
Kaplan, Gilaad G. .
LANCET, 2017, 390 (10114) :2769-2778
[8]   Renal effects of long-term treatment with 5-aminosalicylic acid [J].
Patel, Harshna ;
Barr, Aiala ;
Jeejeebhoy, Khursheed N. .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 23 (03) :170-176
[9]   Mechanisms of Disease: Inflammatory Bowel Diseases [J].
Ramos, Guilherme Piovezani ;
Papadakis, Konstantinos A. .
MAYO CLINIC PROCEEDINGS, 2019, 94 (01) :155-165
[10]   Pediatric Ulcerative Colitis: A Practical Guide to Management [J].
Regan, Brian P. ;
Bousvaros, Athos .
PEDIATRIC DRUGS, 2014, 16 (03) :189-198
12